Keywords: cv, benefits, knoll, sibutramine, ag, anti-obesity, drug

CV benefits with Knoll's sibutramine

Article | 06 November 2000

Knoll AG's anti-obesity drug Meridia/Reductil (sibutramine) may alsohave potential in reducing the risk of coronary heart disease, according to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Meridia

Sibutramine Hydrochloride Monohydrate

Go to drug listing